外突触局部化对于α5GABA A受体调节多巴胺系统功能至关重要
bioRxiv : the preprint server for biology
|July 28, 2023
概括
超突触胺黄油酸A型受体 (GABAAR) 对于调节多巴胺系统功能至关重要. 将这些受体转移到突触中,可以防止α5阳性全调节剂 (α5-PAMs) 的治疗作用,从而影响潜在的抗精神病治疗.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 多巴胺系统功能障碍与精神病有关.
- 胺黄油酸A型受体 (GABAAR) 在调节多巴胺活性方面表现出差异性的有效性.
- α5GABAA Rs主要是外突触的,而α1GABAA Rs则是突触的.
研究的目的:
- 为了研究超突触α5GABAAR局部化在多巴胺系统调节中的作用.
- 确定将α5GABAA Rs转移到突触是否会影响α5-阳性全调节剂 (α5-PAMs) 的疗效.
主要方法:
- 使用小干扰性核糖核酸 (siRNA) 来击倒大鼠腹部海马体 (vHipp) 中的放射素.
- 用radixin knockdown将α5GABAA Rs从突触部位转移到突触部位.
- 用GL-II-73 (一种α5-PAM) 来评估它在激素敲击后对多巴胺神经元活动的影响.
主要成果:
- 激素敲击成功降低了超突触α5GABAA Rs,并增加了突触α5GABAA Rs.
- GL-II-73失去了它调节多巴胺神经元活动的能力,在大鼠中减少了激素.
- α5GABAA Rs的突触局部化对于海马体对多巴胺系统的调节至关重要.
结论:
- α5GABAA Rs的超突触位置对于它们在调节多巴胺系统功能的作用至关重要.
- 像GL-II-73这样的α5-PAMs的疗效可能会在异常的海马活动有利于突触α5GABA的条件下减弱.
- 这些发现对α5-PAMs在治疗精神病中的临床应用有影响.
更多相关视频
11:57Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
Published on: March 28, 2014
15.9K
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
17.5K
相关概念视频
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
